Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation
Author(s) -
Angélica de L. Rodríguez López,
MyungRyul Lee,
Nathan Wang,
Kaitlin K. Dunn,
Hiram Sánchez,
Namrata Raman,
David R. Andes,
David M. Lynn,
Sean P. Palecek
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02653-18
Subject(s) - candida albicans , biofilm , morphogenesis , microbiology and biotechnology , small molecule , chemistry , biology , biophysics , biochemistry , bacteria , genetics , gene
Candida albicans is an opportunistic fungal pathogen responsible for mucosal candidiasis and systemic candidemia in humans. Often, these infections are associated with the formation of drug-resistant biofilms on the surfaces of tissues or medical devices. Increased incidence ofC. albicans resistance to current antifungals has heightened the need for new strategies to prevent or eliminate biofilm-related fungal infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom